Xu Zhenyu 4

What Happened
Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS (SOPH), sold 600 shares on April 14, 2026. The reported weighted-average sale price was $4.97 per share, for total proceeds of approximately $2,980. This was a sale (routine disposition), not a purchase.

Key Details

• Transaction date: 2026-04-14; Form 4 filed 2026-04-16 (timely — within the 2-business-day reporting window).
• Prices: weighted average $4.97; actual sale prices ranged from $4.82 to $5.16 (multiple trades).
• Shares sold: 600; proceeds ≈ $2,980.
• Shares owned after transaction: not disclosed in the excerpt provided.
• Footnotes: (F1) Sale made pursuant to a pre-established Rule 10b5-1 trading plan; (F2) reported price is a weighted average and the filer can provide a breakdown of the number sold at each price on request.
• No indication of late filing.

Context: Sales made under 10b5-1 plans are typically pre-scheduled and often represent routine portfolio management rather than a real-time signal about company prospects. The dollar amount here is small, so this transaction is unlikely by itself to indicate material insider conviction.